Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Pavel Levkin Is Granted Heinz Maier-Leibnitz Prize

Pavel LevkinPhoto: Markus Breig/KIT
Pavel Levkin

Photo: Markus Breig/KIT

Abstract:
The chemist Dr. Pavel Levkin of Karlsruhe Institute of Technology (KIT) is granted the 2015 Heinz Maier-Leibnitz Prize by the German Research Foundation (DFG). The prize is considered the highest distinction for young researchers in Germany. Scientific work of Pavel Levkin focuses on the investigation of cell-surface interactions, the development of biofunctional materials and super-water-repellent surfaces as well as on nanoparticles for specific medicine and gene transport. A major scientific success of Levkin was the synthesis of lipid-like molecules for gene modification of cells.

Pavel Levkin Is Granted Heinz Maier-Leibnitz Prize

Karlsruhe, Germany | Posted on April 8th, 2015

"Polymer chemistry develops new synthesis methods for innovative materials with so far unreached properties and has a high potential for future use," KIT President Professor Holger Hanselka explains. "An important application is molecular cell biology. Based on his excellent understanding of polymer chemistry and biology, Pavel Levkin made major contributions. I am extraordinarily happy that this great achievement is now honored by the important Heinz Maier-Leibnitz Prize."

The Heinz Maier-Leibnitz Prize is granted annually by the DFG to young scientists for outstanding achievements. The prize does not only account for the doctoral thesis, but also considers the fact that the winners have already developed a scientific standing of their own after their doctorate. The distinction is to provide an incentive for the scientists to continue their scientific career. Ten prizes in the amount of EUR 20.000 each are granted. The funds are made available by the Federal Ministry of Education and Research (BMBF). According to a survey of the journal "Bild der Wissenschaft", the big research organizations consider the Heinz Maier-Leibnitz Prize the third important science award in Germany, after the Gottfried Wilhelm Leibniz Prize of the DFG and the Deutscher Zukunftspreis, the German President's Award for Innovation in Science and Technology. On May 05, the Heinz Maier-Leibnitz Prizes will be handed over officially in Berlin.

Research of Pavel Levkin covers the interface of polymer research, micro-engineering, and biologico-medical applications. He uses his profound knowledge of chemical applications to find new solutions of biological problems. The so far biggest scientific success of Dr. Pavel Levkin was the development of super-water-repellent polymer surfaces, which are now applied for miniaturized cell experiments. Levkin's research team at KIT works on strategies of modifying surfaces that are in contact with cells as well as on the development of new nanoparticles for specific medicine and gene transport. Meanwhile, renowned molecular cell biologists have used Levkin's systems. Based on his work, a spinoff, Incella GmbH, was established.

About the Person
Pavel Levkin was born in Moscow in 1980 and studied chemistry at the Moscow Institute of Fine Chemical Technology. He was conferred his doctorate at the University of Tübingen. After a research stay at the University of Vienna, Levkin started to work as a postdoc at the University of California in Berkeley. Since 2009, he has been working at the Institute of Organic Chemistry (IOC) and at the Institute of Toxicology and Genetics (ITG) of KIT. He heads the Helmholtz Research Group of Biofunctional Materials at KIT and the University of Heidelberg. In 2013, Levkin was granted an ERC starting grant for his work on superhydrophobic-hydrophilic microstructures.

####

About Karlsruhe Institute of Technology
Karlsruhe Institute of Technology (KIT) is a public corporation pursuing the tasks of a Baden-Wuerttemberg state university and of a national research center of the Helmholtz Association. The KIT mission combines the three core tasks of research, higher education, and innovation. With about 9,400 employees and 24,500 students, KIT is one of the big institutions of research and higher education in natural sciences and engineering in Europe.

Since 2010, the KIT has been certified as a family-friendly university.

For more information, please click here

Contacts:
Monika Landgraf
Karlsruher Institut für Technologie
+49 721 608 47414

Copyright © AlphaGalileo

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Chemistry

Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Discoveries

Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Materials/Metamaterials/Magnetoresistance

New material to make next generation of electronics faster and more efficient With the increase of new technology and artificial intelligence, the demand for efficient and powerful semiconductors continues to grow November 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

New discovery aims to improve the design of microelectronic devices September 13th, 2024

Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024

Atomic force microscopy in 3D July 5th, 2024

Aston University researcher receives £1 million grant to revolutionize miniature optical devices May 17th, 2024

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project